Usage Patterns of Anticoagulant Therapy in Patients with Mild Cognitive Impairment or Alzheimer’s Disease
Haixin Zhang, Quanwu Zhang, Amir Abbas Tahami Monfared, Michael C Irizarry · 2025
Read Usage Patterns of Anticoagulant Therapy in Patients with Mild Cognitive Impairment or Alzheimer’s Disease by Haixin Zhang, Quanwu Zhang, Amir Abbas Tahami Monfared, Michael C Irizarry (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714491.txt.
Description
Haixin Zhang and co-authors describe how blood thinners are actually used by Americans whose memory is failing, in this 2025 study. Patients with mild cognitive impairment or Alzheimer's still develop the clots and rhythm problems that call for anticoagulants, yet their bleeding risk and adherence worries complicate prescribing. Medicare claims from 2008 to 2018 supplied the lens, with over twenty-one thousand new users sampled from 2016 to 2017. Baseline health was charted for the year before therapy began.
Stable therapy meant at least four weeks of continued use, and a nested comparison hunted the traits tied to stopping or never stabilizing. Real-world patterns like these tell clinicians where support, simpler regimens, or closer follow-up could keep a vulnerable group protected.
Catalog record
| CREATOR | Haixin Zhang, Quanwu Zhang, Amir Abbas Tahami Monfared, Michael C Irizarry |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |